AQP4 and myelitis: In both studies patients, neuromyelitis optica patients, as defined by 2006 Wingerchuk criteria, regardless of AQP4-IgG expression or AQP4-IgG seropositive NMOSD patients with either single or recurrent events of myelitis or optic neuritis, were included [36,37].